retatrutide clinical trial results 2024 2025 press release A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity October 27, 2025: U.K. regulators
Pay in 4 interest-free payments of $5.59 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



























